AngioDynamics Inc at Needham Healthcare Conference (Virtual) Transcript
All right. Good afternoon, everyone. Thanks for joining us at the 21st annual Needham healthcare conference. I'm Mike Matson, senior research analyst on the medtech and diagnostics team.
Next up, we have a presentation from AngioDynamics. Presenting from AngioDynamics is Jim Clemmer, CEO, and Stephen Trowbridge, CFO. Jim and Steve are going to give a quick presentation and then we will follow up with some Q&A. (Conference Instructions)
So with that, I will turn things over to Jim.
Thanks, Mike, and thanks for the conference today. It's been a great conference. So before I talk about specifics about AngioDynamics, let me remind investors that what you hear from Steve and I are our ideas and our direction that we are taking the company. What you hear from us today are the best opportunity for what we believe will happen for us. But as you know, please consider the forward-looking statements, as not everything you hear today we can guarantee
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
